Abstract:The magnitude of the response to a specific immunogen such as an infectious agent is the result of a complex interaction between genetic and environmental factors. For example, in intestinal inflammation, the inflammatory response appears to be regulated by the indigenous microflora of the gut, by receptors in epithelial cells and antigen-presenting cells in the intestinal mucosa, and by immunologic factors. Recent evidence suggests that genetic variants of human immunomodulating genes influence the susceptibility to and severity of infectious diseases and the subsequent clinical outcome of disease. This review will focus on recently identified pattern recognition receptors which are located on innate immune and epithelial cells, and recognize pathogen-associated molecular patterns. The binding of specific pathogen-associated molecular patterns to these receptors results in the activation of a signal transduction pathway through nuclear factor (NF)-kappaB which leads to either enhanced or inhibited immune responses that modify the production of inflammatory effectors, such as cytokines. This article reports on the identification and functional characterization including the discovery of mutants which completely abolish NF-kappaB signal transduction of pattern recognition receptors, such as the extracellular Toll-like receptors and the intracellular nucleotide oligomerization domain/caspase recruitment domain (NOD/CARD) receptors, as well as their role in clinical disease. Knowledge of pattern recognition receptors such as Toll-like receptors and NOD/CARD intracytoplasmic proteins, including their functions and their downstream signaling pathways, may provide a new molecular basis for preventing or blocking inflammation associated with pathogenic microorganisms. This could direct a new focus for better and more specific therapeutic treatments based on immuno-intervention that can promise a better quality of life for those suffering from chronic disturbances of the immune response.

When Innate Immunity Meets Angiogenesis—The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension

Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect

Toll-like receptors in inflammation, infection and cancer

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease

Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling Pathway

Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors

Toll-like Receptor 2 in Promoting Angiogenesis after Acute Ischemic Injury.

Vascular Endothelial Cells and Innate Immunity.

Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

Toll-like receptors as potential therapeutic targets in cardiac dysfunction

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Toll-like receptor signaling and atherosclerosis

Toll-like Receptors: Therapeutic Potential in Life Threatening Diseases- Cardiac Disorders

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response

Advances in Understanding of the Role of Immune Cell Phenotypes in Hypertension and Associated Vascular Disease

Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation

Pathophysiology of Hypertension New paradigms in inflammatory signaling in vascular endothelial cells

Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists

Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases